OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
Provided By GlobeNewswire
Last update: Mar 10, 2025
WALTHAM, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced it has appointed Steve Silvestro as the Company’s new Chief Executive Officer, effective March 10, 2025.
Read more at globenewswire.com
